Skip to main content
. 2023 Feb 10;9(2):e13617. doi: 10.1016/j.heliyon.2023.e13617

Fig. 2.

Fig. 2

GPR65 expression and pan-cancer. (A) Expression of GPR65 in different cancer patients in pathological stages classified by WHO. (B) Expression of GPR65 in cancer patients of different genders.. (C) Analysis of the correlation between GPR65 and age of cancer patients.